Although survival rates for pediatric acute lymphoblastic leukemia are now excellent, this is at the expense of prolonged chemotherapy regimens. We report the long-term immune effects in children treated according to the UK Medical Research Council UKALL 2003 protocol. Peripheral blood lymphocyte subsets and immunoglobulin levels were studied in 116 participants, at six time points, during and for 18-month following treatment, with 30-39 patients analyzed at each time point. Total lymphocytes were reduced during maintenance chemotherapy and remained low 18 months following treatment completion. CD4 T cells remained significantly reduced 18 months after treatment, but CD8 cells and natural killer cells recovered to normal values. The fall in naïve B-cell numbers during maintenance was most marked, but numbers recovered rapidly after cessation of treatment. Memory B cells, particularly nonclass-switched memory B cells, remained below normal levels 18 months following treatment. All immunoglobulin subclasses were reduced during treatment compared to normal values, with IgM levels most affected. This study demonstrates that immune reconstitution differs between lymphocyte compartments. Although total B-cell numbers recover rapidly, disruption of memory/naïve balance persists and T-cell compartment persist at 18 months. This highlights the impact of modern chemotherapy regimens on immunity, and thus, infectious susceptibility and response to immunization.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176016PMC
http://dx.doi.org/10.1002/jha2.27DOI Listing

Publication Analysis

Top Keywords

18 months treatment
12
immune reconstitution
8
chemotherapy regimens
8
normal values
8
b-cell numbers
8
memory b cells
8
treatment
6
reconstitution children
4
chemotherapy
4
children chemotherapy
4

Similar Publications

Introduction: No definitive data exist regarding epidemiology and outcomes of patients treated with open abdomen (OA) linked to age.

Methods: This is a prospective, observational, cohort study that includes patients treated with OA. Patients were divided into 4 age groups: group 1: 16-40 y.

View Article and Find Full Text PDF

Protective studies in sheep immunized with cuticular collagen proteins and peptides of Haemonchus contortus.

Parasite Immunol

May 1991

Animal Health Discovery, Division of Eli Lilly and Company, Greenfield, Indiana 46140.

Twenty-eight nonsibling sheep aged approximately 12 months and raised in a helminth-free environment were used in two protection studies. Immunizations were conducted by two intramuscular injections 30 days apart with a synthetic 18AA cuticle collagen peptide and native cuticle collagens derived from the third- and fourth-stage larvae of Haemonchus contortus. Ten days following the last immunization, the sheep were each given 500 infective H.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!